| Ytd | 50.93% | |
| 1y | -24.54% |
| Open | 0.43 | Prev Close | 0.42 | Low | 0.41 | High | 0.45 | Mkt Cap | 36.92M |
| Vol | 93.16K | Avg Vol | 151.99K | EPS | -0.05 | P/E | N/A | Forward P/E | -21.75 |
| Beta | 1.08 | Short Ratio | 1.65 | Inst. Own | 5.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.45 | 200-d Avg | 0.35 | 1yr Est | 2.13 |
ROSELAND, N.J., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS),
Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that